BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36710292)

  • 1. Active surveillance in renal transplant patients with prostate cancer: a multicentre analysis.
    Soeterik TFW; van den Bergh RCN; van Melick HHE; Kelder H; Peretti F; Dariane C; Timsit MO; Branchereau J; Mesnard B; Tilki D; Olsburgh J; Kulkarni M; Kasivisvanathan V; Breda A; Biancone L; Gontero P; Gandaglia G; Marra G;
    World J Urol; 2023 Mar; 41(3):725-732. PubMed ID: 36710292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer characteristics and outcome in renal transplant recipients: results from a contemporary single center study.
    Pettenati C; Jannot AS; Hurel S; Verkarre V; Kreis H; Housset M; Legendre C; Méjean A; Timsit MO
    Clin Transplant; 2016 Aug; 30(8):964-71. PubMed ID: 27251769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robotic Radical Prostatectomy for Prostate Cancer in Renal Transplant Recipients: Results from a Multicenter Series.
    Marra G; Agnello M; Giordano A; Soria F; Oderda M; Dariane C; Timsit MO; Branchereau J; Hedli O; Mesnard B; Tilki D; Olsburgh J; Kulkarni M; Kasivisvanathan V; Breda A; Biancone L; Gontero P;
    Eur Urol; 2022 Dec; 82(6):639-645. PubMed ID: 35750583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radical Prostatectomy for Nonmetastatic Prostate Cancer in Renal Transplant Recipients: Outcomes for a Large Contemporary Cohort and a Matched Comparison to Patients Without a Transplant.
    Marra G; Tappero S; Barletta F; Marquis A; Allasia M; Oderda M; Dariane C; Timsit MO; Branchereau J; Mesnard B; Tilki D; Olsburgh J; Kulkarni M; Kasivisvanathan V; Lebacle C; Breda A; Galfano A; Gandaglia G; Briganti A; Montorsi F; Biancone L; Gontero P;
    Eur Urol Focus; 2024 Mar; ():. PubMed ID: 38453584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Our experience in the management of prostate cancer in renal transplant recipients.
    Narváez A; Suarez J; Riera L; Castells-Esteve M; Cocera R; Vigués F
    Actas Urol Esp (Engl Ed); 2018 May; 42(4):249-255. PubMed ID: 29395386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer treatment in renal transplant recipients: a systematic review.
    Marra G; Dalmasso E; Agnello M; Munegato S; Bosio A; Sedigh O; Biancone L; Gontero P
    BJU Int; 2018 Mar; 121(3):327-344. PubMed ID: 28921938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over-diagnosed prostate cancer in solid organ recipients: lessons from the last 3 decades.
    Waeckel T; Ait Said K; Altieri M; Belin A; Doerfler A; Tillou X
    Int Urol Nephrol; 2021 Feb; 53(2):241-248. PubMed ID: 32926314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active Surveillance for Prostate Cancer in a Real-life Cohort: Comparing Outcomes for PRIAS-eligible and PRIAS-ineligible Patients.
    Soeterik TFW; van Melick HHE; Dijksman LM; Biesma DH; Witjes JA; van Basten JA
    Eur Urol Oncol; 2018 Aug; 1(3):231-237. PubMed ID: 31102626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate Cancer in Renal Transplant Recipients: Results from a Large Contemporary Cohort.
    Marra G; Soria F; Peretti F; Oderda M; Dariane C; Timsit MO; Branchereau J; Hedli O; Mesnard B; Tilki D; Olsburgh J; Kulkarni M; Kasivisvanathan V; Lebacle C; Rodriguez-Faba O; Breda A; Soeterik T; Gandaglia G; Todeschini P; Biancone L; Gontero P; On Behalf Of The Collaborators
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal High-Intensity Focused Ultrasound vs. Active Surveillance for ISUP Grade 1 Prostate Cancer: Medium-Term Results of a Matched-Pair Comparison.
    Marra G; Soeterik T; Oreggia D; Tourinho-Barbosa R; Moschini M; Stabile A; Filippini C; van Melick HH; van den Bergh RC; Gontero P; Pasquali C; Macek P; Cathala N; Sanchez-Salas R; Cathelineau X
    Clin Genitourin Cancer; 2022 Dec; 20(6):592-604. PubMed ID: 35918262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer in 432 men aged <50 years in the prostate-specific antigen era: a new outlook.
    Gielchinsky I; Chang J; Cusick T; Delprado W; Nguyen Q; Yuen C; Savdie R; Böhm M; Haynes AM; Scheltema MJ; Stricker PD
    BJU Int; 2018 Nov; 122 Suppl 5():35-41. PubMed ID: 30303599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer.
    Bul M; van den Bergh RC; Zhu X; Rannikko A; Vasarainen H; Bangma CH; Schröder FH; Roobol MJ
    BJU Int; 2012 Dec; 110(11):1672-7. PubMed ID: 22928973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort.
    Tosoian JJ; Mamawala M; Epstein JI; Landis P; Macura KJ; Simopoulos DN; Carter HB; Gorin MA
    Eur Urol; 2020 Jun; 77(6):675-682. PubMed ID: 31918957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Course of Candidate Renal Transplant Recipients Diagnosed With Prostate Cancer During Pre-transplant Screening Test.
    Kobari Y; Iizuka J; Nagahisa C; Minoda R; Unagami K; Yoshida K; Hirai T; Shimizu T; Ishida H; Takagi T
    In Vivo; 2024; 38(1):496-499. PubMed ID: 38148097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term Outcomes of Focal Cryotherapy for Low- to Intermediate-risk Prostate Cancer: Results and Matched Pair Analysis with Active Surveillance.
    Marra G; Soeterik T; Oreggia D; Tourinho-Barbosa R; Moschini M; Filippini C; van Melick HHE; van den Bergh RCN; Gontero P; Cathala N; Macek P; Sanchez-Salas R; Cathelineau X
    Eur Urol Focus; 2022 May; 8(3):701-709. PubMed ID: 33926838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and treatment of prostate cancers in renal-transplant recipients.
    Cormier L; Lechevallier E; Barrou B; Benoit G; Bensadoun H; Boudjema K; Descottes JL; Doré B; Guy L; Malavaud B; Martin X; Patard JJ; Petit J; Salomon L
    Transplantation; 2003 Jan; 75(2):237-9. PubMed ID: 12548131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active surveillance for prostate cancer: comparison between incidental tumors vs. tumors diagnosed at prostate biopsies.
    Luzzago S; Piccinelli ML; Marvaso G; Laukhtina E; Miura N; Schuettfort VM; Mori K; Aydh A; Ferro M; Mistretta FA; Fusco N; Petralia G; Jereczek-Fossa BA; Shariat SF; Karakiewicz PI; de Cobelli O; Musi G
    World J Urol; 2022 Feb; 40(2):443-451. PubMed ID: 34687344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation and Active Treatment versus Active Surveillance of Localized Prostate Cancer in Renal Transplant Patients in the Era of Low and Very Low Risk Prostate Cancer.
    Aminsharifi A; Simon R; Polascik TJ; Robertson CN; Sudan DL; Collins BH; Moul JW
    J Urol; 2019 Sep; 202(3):469-474. PubMed ID: 30835631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radical prostatectomy outcomes in renal transplant recipients: a retrospective case series of Thai patients.
    Sirisopana K; Jenjitranant P; Sangkum P; Kijvikai K; Pacharatakul S; Leenanupunth C; Kochakarn W; Kongchareonsombat W
    BMC Urol; 2021 Jul; 21(1):97. PubMed ID: 34229680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.